Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Total Debt (2019 - 2021)

Historic Total Debt for CureVac (CVAC) over the last 3 years, with Q3 2021 value amounting to $32.5 million.

  • CureVac's Total Debt changed N/A to $32.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $32.5 million, marking a year-over-year change of. This contributed to the annual value of $30.0 million for FY2020, which is 5826.93% down from last year.
  • Per CureVac's latest filing, its Total Debt stood at $32.5 million for Q3 2021.
  • In the past 5 years, CureVac's Total Debt ranged from a high of $72.0 million in Q4 2019 and a low of $30.0 million during Q4 2020
  • Its 3-year average for Total Debt is $41.7 million, with a median of $32.3 million in 2021.
  • The largest annual percentage gain for CureVac's Total Debt in the last 5 years was 5826.93% (2020), contrasted with its biggest fall of 5826.93% (2020).
  • CureVac's Total Debt (Quarter) stood at $72.0 million in 2019, then crashed by 58.27% to $30.0 million in 2020, then rose by 8.15% to $32.5 million in 2021.
  • Its last three reported values are $32.5 million in Q3 2021, $32.2 million for Q2 2021, and $30.0 million during Q4 2020.